Sequential dermal microvascular and perivascular changes in the development of scleroderma
- PMID: 1517881
- DOI: 10.1002/path.1711660307
Sequential dermal microvascular and perivascular changes in the development of scleroderma
Abstract
It has been previously proposed that there is a primary microvascular abnormality in patients with systemic sclerosis. In this study using conventional light and electron microscopy, immunohistochemistry, and labelled adenosine uptake techniques, changes in the dermal microvasculature have been related to the various clinical stages of skin disease in systemic sclerosis. The earliest pathological changes are seen in clinically normal skin. They constitute changes in endothelial cell function and their consequences. Perivascular oedema is an early feature. With progression in the clinical disease, there is, at first, an inflammatory cell infiltrate into the dermis, particularly the papillary and mid-dermis, and platelet aggregation within vessels. Further clinical progression is associated with increasing dermal fibrosis, loss of adnexae, and vascular effacement. It is postulated that the recruitment of different types of mononuclear cells into the dermis is causally linked with the preceding endothelial cell dysfunction and the subsequent induction of fibroblast proliferation and collagen synthesis.
Similar articles
-
Vascular damage and lack of angiogenesis in systemic sclerosis skin.Clin Rheumatol. 2003 Sep;22(3):196-202. doi: 10.1007/s10067-003-0698-1. Clin Rheumatol. 2003. PMID: 14505210
-
Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.Circulation. 2009 Dec 8;120(23):2367-76. doi: 10.1161/CIRCULATIONAHA.109.855114. Epub 2009 Nov 23. Circulation. 2009. PMID: 19933934
-
Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis.J Rheumatol. 2011 Feb;38(2):297-301. doi: 10.3899/jrheum.100767. Epub 2010 Nov 15. J Rheumatol. 2011. PMID: 21078716
-
Potential benefit of statins for vascular disease in systemic sclerosis.Curr Opin Rheumatol. 2006 Nov;18(6):594-600. doi: 10.1097/01.bor.0000245720.02512.3e. Curr Opin Rheumatol. 2006. PMID: 17053504 Review.
-
Activation of dermal connective tissue in scleroderma.Ann Med. 1993 Dec;25(6):511-8. Ann Med. 1993. PMID: 8292298 Review.
Cited by
-
Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment.Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):175-182. doi: 10.55563/clinexprheumatol/7ulgbj. Epub 2018 Sep 20. Clin Exp Rheumatol. 2018. PMID: 30277867 Free PMC article. Review.
-
IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis.Front Immunol. 2018 Jul 10;9:1611. doi: 10.3389/fimmu.2018.01611. eCollection 2018. Front Immunol. 2018. PMID: 30042768 Free PMC article.
-
Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers.Clin Exp Immunol. 1998 Nov;114(2):293-300. doi: 10.1046/j.1365-2249.1998.00721.x. Clin Exp Immunol. 1998. PMID: 9822290 Free PMC article.
-
Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension.Thorax. 1997 Dec;52(12):1051-5. doi: 10.1136/thx.52.12.1051. Thorax. 1997. PMID: 9516898 Free PMC article.
-
Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist's, Clinician's, and Patient's Perspective.Clin Rev Allergy Immunol. 2018 Dec;55(3):312-331. doi: 10.1007/s12016-017-8636-1. Clin Rev Allergy Immunol. 2018. PMID: 28866756 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical